• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

ChemoMetec

377.80 DKK

+0.85 %

Less than 1K followers

CHEMM

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Investor consensus
Compare
+0.85 %
+20.55 %
-5.46 %
-45.05 %
-46.11 %
-28.85 %
-26.64 %
-52.09 %
+1,617.27 %

ChemoMetec specializes in the design, development, and production of patented instruments for cell counting and cell analysis. The company cooperates and statutes agreements with actors such as research institutes, universities, food companies, hospitals, and specialist clinics. Customers are found in a global market. The company was founded in 1997 and is headquartered in Alleröd, Denmark.

Read more
Market cap
6.57B DKK
Turnover
19.9M DKK
Revenue
495.57M
EBIT %
47.73 %
P/E
35.28
Dividend yield-%
1.85 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
10.9
2026

Annual report '26

8.10
2026

General meeting '26

All
Research
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

HCA Morgenbørs 26/05 - Lukkede markeder ser ud til at skulle catche op på mandagens stigninger
Video5/26/2026, 7:13 AM by
Michael Friis, Rasmus Køjborg

HCA Morgenbørs 26/05 - Lukkede markeder ser ud til at skulle catche op på mandagens stigninger

I dagens Morgenbørs ser vi ind i blandede futures fra morgenstunden. Herhjemme, lukkede markeder ser ud til at skulle catche op på mandagens stigninger.

ChemoMetecRockwoolGrønlandsbankenTCM GroupLundbeckNovo Nordisk
HCA Morgenbørs 18/05 - Negative futures og lange renter stiger
Video5/18/2026, 7:18 AM by
Michael Friis, Victor Skriver

HCA Morgenbørs 18/05 - Negative futures og lange renter stiger

I dagens Morgenbørs ser vi ind i negative futures, lange renter stiger. Herhjemme er der fokus på Novo, NKT, RTX og Chemometec.

NKTChemoMetecA.P. Møller - MærskRTXNovo NordiskGN Store NordColoplastTorm
Regulatory press release5/15/2026, 9:43 AM

Initiation of buy-back programme

ChemoMetec

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/15/2026, 9:43 AM

Iværksættelse af aktietilbagekøbsprogram

ChemoMetec
HCA Morgenbørs 07/05 - Fokus på danske regnskaber
Video5/7/2026, 7:24 AM by
Victor Skriver, Michael Friis

HCA Morgenbørs 07/05 - Fokus på danske regnskaber

I dagens Morgenbørs ser vi ind i et positivt futuresmarked, drevet af rygter om, at Iran og USA er ved at nå til enighed. Herhjemme er der endnu en regnskabsdag i vente med regnskaber fra bl.a. Mærsk, Zealand Pharma, GN Store Nord og ChemoMetec.

A.P. Møller - MærskNovo NordiskZealand PharmaChemoMetecGomSpaceGN Store Nord
Regulatory press release5/6/2026, 4:52 PM

Vækst i omsætning og driftsresultat

ChemoMetec
Regulatory press release5/6/2026, 4:52 PM

Growth in revenue and operating profit

ChemoMetec
Regulatory press release5/4/2026, 1:17 PM

Tilpasning af regnskabsmæssigt skøn bidrager til opjustering af omsætning og driftsresultat

ChemoMetec
Regulatory press release5/4/2026, 1:17 PM

Adjustment of accounting estimates contributes to an upgrade of revenue and operating profit guidance

ChemoMetec
Regulatory press release3/27/2026, 9:06 AM

Notification of managers’ transactions

ChemoMetec
Regulatory press release3/27/2026, 9:06 AM

Indberetning af ledende medarbejderes transaktioner

ChemoMetec
Regulatory press release3/27/2026, 8:53 AM

Indberetning af ledende medarbejderes transaktioner

ChemoMetec
Regulatory press release3/27/2026, 8:53 AM

Notification of managers’ transactions

ChemoMetec
Regulatory press release3/26/2026, 10:40 AM

Notification of managers’ transactions

ChemoMetec
Regulatory press release3/26/2026, 10:40 AM

Indberetning af ledende medarbejderes transaktioner

ChemoMetec
HCA Morgenbørs 26/03 - Røde futures fra morgenstunden
Video3/26/2026, 8:19 AM by
Michael Friis, Rasmus Køjborg

HCA Morgenbørs 26/03 - Røde futures fra morgenstunden

I dagens Morgenbørs ser vi ind i røde futures fra morgenstunden, Iran har ikke fundet afkørselsrampen. Herhjemme fokus på blandt andet Mærsk, Chemometec og Bioporto.

SP GroupGrønlandsbankenA.P. Møller - MærskChemoMetecØrstedVestas Wind SystemsBioPortoPandoraNovo Nordisk
HCA Morgenbørs 25/03 - Positive markeder og hele linjen
Video3/25/2026, 8:24 AM by
Rasmus Køjborg, Victor Skriver

HCA Morgenbørs 25/03 - Positive markeder og hele linjen

I dagens Morgenbørs ser vi med grønne futures-kurser ind i positive markeder over hele linjen. Herhjemme fokus på blandt andet Novonesis, SP Group, DFDS, Chemometec og B&O.

SP GroupDFDSTormHafniaBang & OlufsenD/S NordenFLSmidth & Co.NovonesisDanish Aerospace and Defence CompanyFirstFarmsChemoMetec
Regulatory press release3/24/2026, 3:08 PM

Justering af forventningerne til 2025/26

ChemoMetec
Regulatory press release3/24/2026, 3:08 PM

Adjustment of guidance for 2025/26

ChemoMetec
Regulatory press release3/2/2026, 9:50 AM

Notification of managers’ transactions

ChemoMetec